Azoospermia is the complete absence of sperm in the ejaculate, confirmed on two separate centrifuged semen samples. It is found in approximately 1% of the general male population and in roughly 10–15% of men presenting with infertility (Jarow et al., Journal of Urology; ASRM Practice Committee guidance in Fertility and Sterility). Modern reproductive medicine allows most of these men to achieve biological fatherhood when evaluated and treated correctly.
Two Major Categories
Clinically, azoospermia is divided into two groups, each with distinct causes and treatment pathways:
- Obstructive azoospermia (OA): Normal sperm production, but a blockage prevents sperm from reaching the ejaculate. Accounts for roughly 40% of cases.
- Non-obstructive azoospermia (NOA): Impaired or absent sperm production within the testis. Accounts for roughly 60% of cases and is the more challenging form to treat.
Causes
Obstructive: vasectomy, congenital bilateral absence of the vas deferens (often associated with CFTR mutations), infections of the epididymis, iatrogenic injury, or ejaculatory duct obstruction.
Non-obstructive: genetic causes such as Klinefelter syndrome (47,XXY) and Y-chromosome microdeletions (AZFa, AZFb, AZFc), cryptorchidism, prior chemotherapy or radiotherapy, testicular torsion, mumps orchitis, hypogonadotropic hypogonadism, or idiopathic in many cases. Reviews in Human Reproduction Update and Fertility and Sterility have repeatedly highlighted the importance of genetic workup before treatment.
Diagnostic Evaluation
- History and examination: Pubertal development, prior surgeries, infections, medication, testicular volume, presence or absence of the vas deferens.
- Repeat semen analysis with centrifugation, performed according to the WHO 6th edition laboratory manual.
- Hormone profile: FSH, LH, testosterone, and prolactin. Elevated FSH with small testes suggests NOA; normal FSH and volume typically suggest OA.
- Genetic testing: Karyotype, Y-chromosome microdeletion analysis, and CFTR mutation screening where appropriate.
- Scrotal and transrectal ultrasound: To detect varicocele, epididymal dilation, or ejaculatory duct obstruction.
Treatment of Obstructive Azoospermia
Reconstructive microsurgery (vasovasostomy or vasoepididymostomy) can restore natural fertility in selected men. When reconstruction is not feasible or unsuccessful, surgical sperm retrieval techniques such as PESA (percutaneous epididymal sperm aspiration), MESA (microsurgical epididymal sperm aspiration), or TESA (testicular sperm aspiration) combined with IVF/ICSI are highly successful. Sperm retrieval rates exceed 90% in OA cases.
Treatment of Non-Obstructive Azoospermia
For NOA, microdissection testicular sperm extraction (micro-TESE), first described by Schlegel (Human Reproduction, 1999), is now considered the gold standard. It achieves sperm retrieval in approximately 40–60% of men with NOA, depending on the underlying cause, while removing significantly less testicular tissue than conventional TESE. Retrieved sperm are used immediately or cryopreserved for ICSI. In men with hypogonadotropic hypogonadism, gonadotropin therapy can often restore spermatogenesis without surgery.
Genetic Counselling
Because certain genetic abnormalities such as Y-chromosome microdeletions are heritable, and Klinefelter syndrome and CFTR mutations carry specific reproductive implications, genetic counselling is an essential part of the care pathway for any man with azoospermia before initiating treatment.
Azoospermia is not the end of the road. With a structured evaluation, genetic assessment, and access to modern microsurgical and laboratory techniques, most men can be offered a realistic path to biological fatherhood.
References drawn from peer-reviewed literature including Schlegel PN (Human Reproduction, 1999); Donoso, Tournaye, Devroey (Human Reproduction Update, 2007); ASRM Practice Committee, Fertility and Sterility; European Association of Urology male infertility guidelines; and the WHO laboratory manual for the examination and processing of human semen (6th edition).